/PRNewswire/ The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around.
Stem Cell Therapy Market | No. of pages: 112| research report focus on overall information that can help to take decisions on current market situation. Stem
LONDON, Nov. 1, 2022 /PRNewswire/ Stem Cell Therapy Global Market Report 2022", grew from $ 197.30 Million in 2021 to $ 554.25 Million in 2028 at a growth rate (CAGR) of 15.90%. Stem
Catalent Acquires Additional Facility at its Gosselies, Belgium Campus for Commercial-Scale Plasmid DNA Manufacturing
Share Article
Catalent, the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products, and Promethera Biosciences, the world leader in advanced therapy development for severe liver diseases, today announced that Catalent has acquired Promethera’s cell therapy manufacturing subsidiary, Hepatic Cell Therapy Support SA (HCTS), including its 32,400 square-foot (3,010 square-meter) facility in Gosselies, Belgium. The facility will accommodate Catalent’s new commercial-scale plasmid DNA (pDNA) manufacturing and will provide the opportunity for the immediate growth of Catalent’s pDNA service offering, which was recently acquired from Delphi Genetics to support the growing cell and gene therapy pipeline.